News Feed

In a groundbreaking study, scientists have genetically engineered hookworms to produce and deliver therapeutic molecules from inside a living host. Using CRISPR gene-editing technology, researchers modified the parasite Ancylostoma ceylanicum to secrete an antibody capable of partially neutralizing tetrodotoxin, the deadly poison found in pufferfish.Tests in hamsters showed that the engineered worms successfully released the antitoxin into the bloodstream, demonstrating a completely new approach to drug delivery. Researchers believe future versions could be designed to treat chronic conditions such as inflammatory bowel disease, food allergies, and type 2 diabetes. Because hookworm infections can be easily controlled and eliminated with standard treatments, this innovative technology could open the door to a new generation of living, self-sustaining medicines.

In a groundbreaking achievement, scientists have successfully translated and uploaded the complete genome of the hepatitis D virus (HDV) onto IBM’s 156-qubit Heron quantum computer. This marks the first time a real viral genome has been encoded in a quantum-compatible format for analysis.The research team demonstrated key genomic tasks, including DNA sequence alignment, pangenome assembly, and evolutionary mapping, directly on quantum hardware. Researchers believe quantum computing could eventually tackle complex biological problems that overwhelm even advanced classical computers and AI systems.While practical applications are still years away, this milestone could pave the way for faster disease tracking, improved rare disease research, and more efficient identification of disease-causing mutations, opening a new era in genomics and precision medicine.

Many people expect the scale to drop quickly after replacing sugary soft drinks with juice, coconut water, or zero-sugar alternatives. However, experts say weight loss is often more complex than a single dietary swap. While reducing sugar-sweetened beverages can lower calorie intake and support better health, lasting weight loss depends on overall eating habits, physical activity, and total daily calorie consumption. In some cases, people may unknowingly compensate by consuming extra calories elsewhere or choosing “healthy” drinks that still contain significant amounts of sugar. According to specialists, replacing sugary beverages is a positive first step, but meaningful and sustainable weight loss requires a broader approach focused on long-term lifestyle changes.

A new study from Delhi suggests that the age-old belief that almonds are good for the brain may have scientific backing. Researchers found that middle-aged adults who consumed a daily handful of almonds for 24 weeks showed improvements in thinking speed, concentration, decision-making, and mental agility. The randomized controlled trial, published in The Journal of Nutrition, involved 60 prediabetic Asian Indian adults. Beyond cognitive benefits, participants who ate almonds also experienced better blood sugar control, reduced inflammation, and modest weight loss compared to those on a calorie-matched control diet. The findings highlight almonds as a simple dietary addition that may support both brain and metabolic health.

Many people undergoing chemotherapy experience “chemo brain,” a condition that can affect memory, focus, and everyday thinking skills. A new clinical trial suggests that a simple home-based exercise program may help reduce these cognitive challenges. Researchers found that cancer patients who followed regular exercise routines showed better attention and reported fewer noticeable cognitive problems compared to those receiving a placebo. The study also found that low-dose ibuprofen improved certain cognitive measures, although the benefits were less consistent than those seen with exercise. These findings highlight the potential of physical activity as a practical, low-cost strategy to support brain health during cancer treatment.

A new study has raised concerns about glucosamine, a widely used supplement for joint pain and arthritis. Researchers found that people with mild cognitive impairment who regularly used glucosamine were about 25% more likely to progress to Alzheimer’s disease compared to non-users. The study also identified potential biological mechanisms that may help explain this association, although the exact cause-and-effect relationship remains unclear. Experts stress that the findings do not prove glucosamine causes Alzheimer’s, and more research is needed to confirm the results. However, the study highlights the importance of evaluating the long-term effects of commonly used supplements, especially among older adults at risk of cognitive decline.

A persistent headache, occasional dizziness, memory lapses, or unexplained fatigue are often blamed on stress, lack of sleep, or migraines. However, experts warn that in some cases these symptoms can signal a brain tumour. While most headaches are not cancer-related, warning signs such as worsening headaches, seizures, vision changes, balance problems, speech difficulties, or sudden changes in behavior should not be ignored. Early diagnosis is crucial, as it can improve treatment options and outcomes. Advances in minimally invasive surgery, AI-assisted navigation, and precision diagnostics are also transforming brain tumour care, helping patients recover faster and improving survival rates.

Many people use the terms “headache” and “migraine” interchangeably, but they are not the same. A headache is a broad term for pain or pressure in the head or neck and can be caused by stress, sinus issues, dehydration, or even uncorrected vision problems. Migraines, on the other hand, are a neurological condition that often causes intense, throbbing pain and may be accompanied by nausea, sensitivity to light or sound, and visual disturbances. Experts also note that recurring headaches can sometimes be linked to refractive errors such as short-sightedness, long-sightedness, or astigmatism. Understanding the difference can help ensure proper treatment and identify symptoms that may require medical attention.

A new case study has sparked interest in the potential of psilocybin-containing mushrooms as a treatment for Alzheimer’s disease. Researchers reported that an 80-year-old woman with advanced Alzheimer’s showed notable improvements in memory, communication, mobility, emotional expression, and daily functioning after receiving psilocybin. The patient had lived with the disease for nearly a decade and required constant care due to severe cognitive decline. While scientists emphasize that the study does not demonstrate a cure or reversal of Alzheimer’s, the findings suggest that some lost brain functions may remain dormant and could potentially be reactivated under certain conditions. Larger clinical studies are needed to confirm these promising early observations.

A new study suggests that ultra-processed foods may be doing more than harming physical health—they could also affect brain function. Researchers from Harvard T.H. Chan School of Public Health found that older adults who consumed the highest amounts of ultra-processed foods, such as chips, biscuits, and sugary drinks, had a 58% higher risk of developing dementia and a 46% higher risk of cognitive impairment compared to those who ate the least. The study followed more than 5,300 adults aged 50 and older for nearly ten years. In contrast, diets rich in minimally processed foods were associated with a significantly lower risk of cognitive decline, highlighting the importance of healthy eating for long-term brain health.